Literature DB >> 9247935

Limited sequence polymorphism in the Plasmodium falciparum merozoite surface protein 3.

W Huber1, I Felger, H Matile, H J Lipps, S Steiger, H P Beck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9247935     DOI： 10.1016/s0166-6851(97)00067-4

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN： 0166-6851            Impact factor:   1.759


× No keyword cloud information.
  29 in total

1.  Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum.

Authors:  A A Escalante; A A Lal; F J Ayala
Journal:  Genetics       Date:  1998-05       Impact factor: 4.562

2.  Malaria immunoepidemiology in low transmission: correlation of infecting genotype and immune response to domains of Plasmodium falciparum merozoite surface protein 3.

Authors:  Stephen J Jordan; Ana L Oliveira; Jean N Hernandez; Robert A Oster; Debasish Chattopadhyay; OraLee H Branch; Julian C Rayner
Journal:  Infect Immun       Date:  2011-03-07       Impact factor: 3.441

3.  Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.

Authors:  Soe Soe; Michael Theisen; Christian Roussilhon; Khin-Saw Aye; Pierre Druilhe
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

4.  Limited variation in vaccine candidate Plasmodium falciparum Merozoite Surface Protein-6 over multiple transmission seasons.

Authors:  Aaron T Neal; Stephen J Jordan; Ana L Oliveira; Jean N Hernandez; Oralee H Branch; Julian C Rayner
Journal:  Malar J       Date:  2010-05-24       Impact factor: 2.979

5.  Genetic diversity of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-3 in a hypoendemic transmission environment.

Authors:  Stephen J Jordan; OraLee H Branch; Juan Carlos Castro; Jean Carlos Castro; Robert A Oster; Julian C Rayner
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

Review 6.  Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.

Authors:  S L Takala; C V Plowe
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

7.  Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.

Authors:  Arunaditya Deshmukh; Bishwanath Kumar Chourasia; Sonali Mehrotra; Ikhlaq Hussain Kana; Gourab Paul; Ashutosh Panda; Inderjeet Kaur; Susheel Kumar Singh; Sumit Rathore; Aparup Das; Priya Gupta; Md Kalamuddin; S K Gakhar; Asif Mohmmed; Michael Theisen; Pawan Malhotra
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

8.  Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of immunogenicity studies in models.

Authors:  Lena-Juliette Daher; Corine G Demanga; Eric Prieur; Jean-Louis Pérignon; Hasnaa Bouharoun-Tayoun; Pierre Druilhe
Journal:  Infect Immun       Date:  2009-07-06       Impact factor: 3.441

Review 9.  The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.

Authors:  Freya J I Fowkes; Jack S Richards; Julie A Simpson; James G Beeson
Journal:  PLoS Med       Date:  2010-01-19       Impact factor: 11.069

10.  Design and pre-clinical profiling of a Plasmodium falciparum MSP-3 derived component for a multi-valent virosomal malaria vaccine.

Authors:  Marco Tamborrini; Markus S Mueller; Sabine A Stoffel; Nicole Westerfeld; Denise Vogel; Francesca Boato; Rinaldo Zurbriggen; John A Robinson; Gerd Pluschke
Journal:  Malar J       Date:  2009-12-30       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.